407 research outputs found
ExoMol molecular line lists - XVI: The rotation-vibration spectrum of hot HS
This work presents the AYT2 line list: a comprehensive list of 114 million
HS vibration-rotation transitions computed using an
empirically-adjusted potential energy surface and an {\it ab initio} dipole
moment surface. The line list gives complete coverage up to 11000 \cm\
(wavelengths longer than 0.91 m) for temperatures up to 2000 K. Room
temperature spectra can be simulated up to 20000 \cm\ (0.5 m) but the
predictions at visible wavelengths are less reliable. AYT2 is made available in
electronic form as supplementary data to this article and at
\url{www.exomol.com}.Comment: 12 pages, 10 figures, 10 table
Experimental Research of the Diffraction and Vavilov-Cherenkov Radiation Generation in a Teflon Target
Geometry of Vavilov-Cherekov (VChR) radiation when an electron moves close to
a dielectric target is in analogy to diffraction radiation (DR) geometry. In
this case we may expect DR generation from the upstream face of the target
besides that VChR. The joint observation of these booth types of radiation is
very interesting from the pseudo-photon viewpoint, which is applicable for
relativistic electrons. Unexpected results obtained in our experiment insist on
reflection about nature both DR and VChR. The experiment was performed on the
relativistic electron beam of the microtron of Tomsk Polytechnic University.Comment: This article will be published in Journal of Physic
Associations of genotype variants of single nucleotide polymorphism of gene orosomucoid-1-like-protein 3 and atopic diseases at children.
The paper presents data of the firstly conducted in Ukraine own study of associations of the single nucleotide polymorphism (SNP) rs7216389 of orsomucoid-1-like protein 3 gene (ORMDL3) variantsβ with atopic diseases in children. Aim: to detect clinical significance of the SNP rs7216389 ORMDL3 in genesis of atopic diseases in children. We examined 153 children aged 3 to 18 years. The main group consisted of 119 children with clinical manifestations of atopic diseases with elevated total serum immunoglobulin E, confirmed by immunofluorescence assay method. The comparison group consisted of 34 children with a non-aggravated individual or family allergic anamnesis in whom there was detected the absence of any clinical syndromes and symptoms of atopic diseases and, mostly, physiological parameters of the serum total immunoglobulin E by immunofluorescence assay method. All the children were genotyped by ORMDL3 gene using polymerase chain reaction in real time with a restricted fragment length polymorphism. The genotype T/TΒ within SNP rs7216389 of ORMDL3 gene significantly prevails among the children with atopic diseases and is associated with an increased incidence risk of seasonal allergic rhinoconjunctivitis (SARC) by 4.11 times (95% CI 1.55; 16.61), perennial allergic rhinitis (PAR) by 5.07 times (95% CI 1.22; 13.90) times and bronchial asthma (BA) by 10.31 times (95% CI 2.50; 42.62). Children with genotype T/T in locus rs7216389 of the ORMDL3 gene are the increased risk group for developing the atopic diseases. Children with genotype C/C in locus rs7216389 of the ORMDL3 gene are the decreased risk group for the development of atopic dermatitis
ΠΠΈΡΠ½ΠΎΠΊΠΈΡΠ»ΠΎΡΠ½ΠΈΠΉ ΡΠΊΠ»Π°Π΄ ΡΠΈΡΠΎΠ²ΠΈΠ½ΠΈ ΠΎΠ±Π»ΡΠΏΠΈΡ ΠΈ ΠΊΡΡΡΠΈΠ½ΠΎΠ²ΠΈΠ΄Π½ΠΎΡ
Today, the relevance of studying medicinal plants and creating medicines based on them occupies a special place in medicine and pharmacy. Interest in the study of already known and new medicinal plants of the domestic flora is growing. On their basis, new herbal medicines and dietary supplements are created, which due to their unique compositionhave a mild therapeutic and complex effect on the organs and systems of the human body. They are virtually devoid of side effects, and they do not develop addiction.
Aim. To study the qualitative composition and the content of fatty acids in the medicinal plant raw material from sea buckthorn using the chromatographic method; to determine the specific feature of the fatty acid composition for identification of the sea buckthorn raw material.
Materials and methods. The study objects were leaves, fruit pulp, seeds and bark of sea buckthorn harvested at the pharmacopoeial garden of the National University of Pharmacy (2018). The analysis was performed using gas chromatography-mass spectrometry (GC/MS).
Results and discussion. The results of the analysis indicate that the medicinal plant raw material from sea buckthorn has a rich diverse composition of saturated and unsaturated fatty acids, namely: in the leaves of sea buckthorn there are significant amounts of fatty acids. Among saturated fatty acids there are palmitic (55.33 mg/g), behenic (1.07 mg/g),stearic (1.03 mg/g), arachinic (0.91 mg/g), lignocerinic (0.78 mg/g), margaric (0.32 mg/g), myristic (0.28 mg/g) acids; among unsaturated fatty acids β oleic (7.79 mg/g), linoleic (2.42 mg/g). Fatty acids of the sea buckthorn bark are representedby saturated arachidonic (20.85 mg/g), palmitic (2.14 mg/g), erucic (2.09 mg/g), heneukocylic (1.87 mg/g),behenic (1.38 mg/g) acids and unsaturated oleic (5.75 mg/g) and linoleic (4.86 m/g) fatty acids. In the pulp of sea buckthorn fruits 9 fatty acids have been identified. Palmitic acid (23.55 mg/g) is contained in large quantities, there are also stearic acid (2.68 mg/g), myristic acid (1.36 mg/g), arachinic acid (0.87 mg/g). Among unsaturated acids, oleic acid (44.42 mg/g), linoleic acid (12.49 mg/g), linolenic acid (5.96 mg/g), palmitoleic acid (5.16 mg/g) and vaccenic acid (3.79 mg/g) have been identified. The seeds of sea buckthorn contain 8 fatty acids. Three of them are saturated: palmitic (15.89 mg/g), stearic (2.51 mg/g), myristic (0.71 mg/g), and there are five unsaturated acids: oleic (31.41 mg/g), linoleic (27.03 mg/g),linolenic (17.00 mg/g), vaccenic (2.86 mg/g) and palmitoleic (2.56 mg/g).
Conclusions. The results of the analysis show a rich fatty acid composition of the medicinal plant raw material from sea buckthorn. It has been determined that the specific feature is the presence and the ratio of palmitoleic and vaccenic acid in the pulp and seeds; this feature is characteristic when identifying the sea buckthorn raw material. Thus, this raw material can be promising for the creation of medicines and dietary supplements based on it, for the treatment and prevention of various diseases.ΠΠ° ΡΠ΅Π³ΠΎΠ΄Π½ΡΡΠ½ΠΈΠΉ Π΄Π΅Π½Ρ Π°ΠΊΡΡΠ°Π»ΡΠ½ΠΎΡΡΡ ΠΈΠ·ΡΡΠ΅Π½ΠΈΡ Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΡΡ
ΡΠ°ΡΡΠ΅Π½ΠΈΠΉ ΠΈ ΡΠΎΠ·Π΄Π°Π½ΠΈΡ Π½Π° ΠΈΡ
ΠΎΡΠ½ΠΎΠ²Π΅ Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΡΡ
ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΎΠ² Π·Π°Π½ΠΈΠΌΠ°Π΅Ρ ΠΎΡΠΎΠ±ΠΎΠ΅ ΠΌΠ΅ΡΡΠΎ Π² ΡΡΠ΅ΡΠ΅ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½Ρ ΠΈ ΡΠ°ΡΠΌΠ°ΡΠΈΠΈ. ΠΠ½ΡΠ΅ΡΠ΅Ρ ΠΊ ΠΈΠ·ΡΡΠ΅Π½ΠΈΡ ΡΠΆΠ΅ ΠΈΠ·Π²Π΅ΡΡΠ½ΡΡ
ΠΈ Π½ΠΎΠ²ΡΡ
Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΡΡ
ΡΠ°ΡΡΠ΅Π½ΠΈΠΉ ΠΎΡΠ΅ΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΎΠΉ ΡΠ»ΠΎΡΡ Π²ΡΓ« Π±ΠΎΠ»Π΅Π΅ Π²ΠΎΠ·ΡΠ°ΡΡΠ°Π΅Ρ. ΠΠ° ΠΈΡ
ΠΎΡΠ½ΠΎΠ²Π΅ ΡΠΎΠ·Π΄Π°ΡΡΡΡ Π½ΠΎΠ²ΡΠ΅ Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΡΠ΅ ΡΡΠ΅Π΄ΡΡΠ²Π° ΡΠ°ΡΡΠΈΡΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ ΠΏΡΠΎΠΈΡΡ
ΠΎΠΆΠ΄Π΅Π½ΠΈΡ ΠΈ Π΄ΠΈΠ΅ΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ Π΄ΠΎΠ±Π°Π²ΠΊΠΈ, ΠΊΠΎΡΠΎΡΡΠ΅ Π±Π»Π°Π³ΠΎΠ΄Π°ΡΡ ΡΠ²ΠΎΠ΅ΠΌΡ ΡΠ½ΠΈΠΊΠ°Π»ΡΠ½ΠΎΠΌΡ ΡΠΎΡΡΠ°Π²Ρ ΠΎΠΊΠ°Π·ΡΠ²Π°ΡΡ ΠΌΡΠ³ΠΊΠΎΠ΅ Π»Π΅ΡΠ΅Π±Π½ΠΎΠ΅ ΠΈ ΠΊΠΎΠΌΠΏΠ»Π΅ΠΊΡΠ½ΠΎΠ΅ Π²ΠΎΠ·Π΄Π΅ΠΉΡΡΠ²ΠΈΠ΅ Π½Π° ΠΎΡΠ³Π°Π½Ρ ΠΈ ΡΠΈΡΡΠ΅ΠΌΡ ΡΠ΅Π»ΠΎΠ²Π΅ΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΎΡΠ³Π°Π½ΠΈΠ·ΠΌΠ°. ΠΠ½ΠΈ ΠΏΡΠ°ΠΊΡΠΈΡΠ΅ΡΠΊΠΈ Π»ΠΈΡΠ΅Π½Ρ ΠΏΠΎΠ±ΠΎΡΠ½ΡΡ
ΡΡΡΠ΅ΠΊΡΠΎΠ², ΠΊ Π½ΠΈΠΌ Π½Π΅ ΡΠ°Π·Π²ΠΈΠ²Π°Π΅ΡΡΡ ΠΏΡΠΈΠ²ΡΠΊΠ°Π½ΠΈΠ΅.
Π¦Π΅Π»Ρ. ΠΠ·ΡΡΠΈΡΡ ΠΊΠ°ΡΠ΅ΡΡΠ²Π΅Π½Π½ΡΠΉ ΡΠΎΡΡΠ°Π² ΠΈ ΡΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅ ΠΆΠΈΡΠ½ΡΡ
ΠΊΠΈΡΠ»ΠΎΡ Π² Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΠΎΠΌ ΡΠ°ΡΡΠΈΡΠ΅Π»ΡΠ½ΠΎΠΌ ΡΡΡΡΠ΅ ΠΊΡΡΡΠΈΠ½ΠΎΠ²ΠΈΠ΄Π½ΠΎΠΉ ΠΎΠ±Π»Π΅ΠΏΠΈΡ
ΠΈ Ρ ΠΏΠΎΠΌΠΎΡΡΡ Ρ
ΡΠΎΠΌΠ°ΡΠΎΠ³ΡΠ°ΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΌΠ΅ΡΠΎΠ΄Π°. ΠΡΡΠ²ΠΈΡΡ Ρ
Π°ΡΠ°ΠΊΡΠ΅ΡΠ½ΡΡ ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΡ ΠΆΠΈΡΠ½ΠΎΠΊΠΈΡΠ»ΠΎΡΠ½ΠΎΠ³ΠΎ ΡΠΎΡΡΠ°Π²Π° Π΄Π»Ρ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΠ³ΠΎ ΡΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½ΠΈΡ ΠΈΠ΄Π΅Π½ΡΠΈΡΠ½ΠΎΡΡΠΈ ΡΡΡΡΡ ΠΎΠ±Π»Π΅ΠΏΠΈΡ
ΠΈ.
ΠΠ°ΡΠ΅ΡΠΈΠ°Π»Ρ ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ. ΠΠ±ΡΠ΅ΠΊΡΠ°ΠΌΠΈ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ Π±ΡΠ»ΠΈ Π»ΠΈΡΡΡΡ, ΠΌΡΠΊΠΎΡΡ ΠΏΠ»ΠΎΠ΄ΠΎΠ², ΡΠ΅ΠΌΠ΅Π½Π° ΠΈ ΠΊΠΎΡΠ° ΠΎΠ±Π»Π΅ΠΏΠΈΡ
ΠΈ ΠΊΡΡΡΠΈΠ½ΠΎΠ²ΠΈΠ΄Π½ΠΎΠΉ, Π·Π°Π³ΠΎΡΠΎΠ²Π»Π΅Π½Π½ΡΠ΅ Π½Π° ΡΠ°ΡΠΌΠ°ΠΊΠΎΠΏΠ΅ΠΉΠ½ΠΎΠΌ ΡΡΠ°ΡΡΠΊΠ΅ ΠΠ€Π°Π£ (2018 Π³.). ΠΠ½Π°Π»ΠΈΠ· ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΠ»ΠΈ Ρ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ Π³Π°Π·ΠΎ- Ρ
ΡΠΎΠΌΠ°ΡΠΎ-ΠΌΠ°ΡΡ-ΡΠΏΠ΅ΠΊΡΡΠΎΠΌΠ΅ΡΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΌΠ΅ΡΠΎΠ΄Π° (ΠΠ₯/ΠΠ‘).
Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ ΠΈ ΠΈΡ
ΠΎΠ±ΡΡΠΆΠ΄Π΅Π½ΠΈΠ΅. Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ Π°Π½Π°Π»ΠΈΠ·Π° ΡΠ²ΠΈΠ΄Π΅ΡΠ΅Π»ΡΡΡΠ²ΡΡΡ ΠΎ ΡΠΎΠΌ, ΡΡΠΎ Π² ΠΠ Π‘ ΠΎΠ±Π»Π΅ΠΏΠΈΡ
ΠΈ ΠΊΡΡΡΠΈΠ½ΠΎΠ²ΠΈΠ΄Π½ΠΎΠΉ Π±ΠΎΠ³Π°ΡΡΠΉ ΠΈ ΡΠ°Π·Π½ΠΎΠΎΠ±ΡΠ°Π·Π½ΡΠΉ ΡΠΎΡΡΠ°Π² Π½Π°ΡΡΡΠ΅Π½Π½ΡΡ
ΠΈ Π½Π΅Π½Π°ΡΡΡΠ΅Π½Π½ΡΡ
ΠΆΠΈΡΠ½ΡΡ
ΠΊΠΈΡΠ»ΠΎΡ. Π Π»ΠΈΡΡΡΡΡ
ΠΎΠ±Π»Π΅ΠΏΠΈΡ
ΠΈ ΠΊΡΡΡΠΈΠ½ΠΎΠ²ΠΈΠ΄Π½ΠΎΠΉ Π½Π°Ρ
ΠΎΠ΄ΡΡΡΡ Π² Π·Π½Π°ΡΠΈΡΠ΅Π»ΡΠ½ΡΡ
ΠΊΠΎΠ»ΠΈΡΠ΅ΡΡΠ²Π°Ρ
ΡΠ°ΠΊΠΈΠ΅ Π½Π°ΡΡΡΠ΅Π½Π½ΡΠ΅ ΠΆΠΈΡΠ½ΡΠ΅ ΠΊΠΈΡΠ»ΠΎΡΡ, ΠΊΠ°ΠΊ ΠΏΠ°Π»ΡΠΌΠΈΡΠΈΠ½ΠΎΠ²Π°Ρ (5,33 ΠΌΠ³/Π³), Π±Π΅Π³Π΅Π½ΠΎΠ²Π°Ρ (1,07 ΠΌΠ³/Π³), ΡΡΠ΅Π°ΡΠΈΠ½ΠΎΠ²Π°Ρ (1,03 ΠΌΠ³/ Π³), Π°ΡΠ°Ρ
ΠΈΠ½ΠΎΠ²Π°Ρ (0,91 ΠΌΠ³/Π³), Π»ΠΈΠ³Π½ΠΎΡΠ΅ΡΠΈΠ½ΠΎΠ²Π°Ρ (0,78 ΠΌΠ³/Π³), ΠΌΠ°ΡΠ³Π°ΡΠΈΠ½ΠΎΠ²Π°Ρ (0,32 ΠΌΠ³/Π³), ΠΌΠΈΡΠΈΡΡΠΈΠ½ΠΎΠ²Π°Ρ (0,28 ΠΌΠ³/Π³); ΠΈ Π½Π΅Π½Π°ΡΡΡΠ΅Π½Π½ΡΠ΅ ΠΆΠΈΡΠ½ΡΠ΅ ΠΊΠΈΡΠ»ΠΎΡΡ β ΠΎΠ»Π΅ΠΈΠ½ΠΎΠ²Π°Ρ (7,79 ΠΌΠ³/Π³), Π»ΠΈΠ½ΠΎΠ»Π΅Π²Π°Ρ (2,42 ΠΌΠ³/Π³). ΠΠΈΡΠ½ΡΠ΅ ΠΊΠΈΡΠ»ΠΎΡΡ ΠΊΠΎΡΡ ΠΎΠ±Π»Π΅ΠΏΠΈΡ
ΠΈ ΠΊΡΡΡΠΈΠ½ΠΎΠ²ΠΈΠ΄Π½ΠΎΠΉ ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½Ρ Π½Π°ΡΡΡΠ΅Π½Π½ΡΠΌΠΈ β Π°ΡΠ°Ρ
ΠΈΠ½ΠΎΠ²ΠΎΠΉ (20,85 ΠΌΠ³/Π³), ΠΏΠ°Π»ΡΠΌΠΈΡΠΈΠ½ΠΎΠ²ΠΎΠΉ (2,14 ΠΌΠ³/Π³), ΡΡΡΠΊΠΎΠ²ΠΎΠΉ (2,09 ΠΌΠ³/Π³), Π³Π΅Π½Π΅ΠΉΠΊΠΎΡΠΈΠ»ΠΎΠ²ΠΎΠΉ (1,87 ΠΌΠ³/Π³), Π±Π΅Π³Π΅Π½ΠΎΠ²ΠΎΠΉ (1,38 ΠΌΠ³/Π³) β ΠΈ Π½Π΅Π½Π°ΡΡΡΠ΅Π½Π½ΡΠΌΠΈ ΠΊΠΈΡΠ»ΠΎΡΠ°ΠΌΠΈ: ΠΎΠ»Π΅ΠΈΠ½ΠΎΠ²ΠΎΠΉ (5,75 ΠΌΠ³/Π³) ΠΈ Π»ΠΈΠ½ΠΎΠ»Π΅Π²ΠΎΠΉ (4,86 ΠΌΠ³/Π³). Π ΠΌΡΠΊΠΎΡΠΈ ΠΏΠ»ΠΎΠ΄ΠΎΠ² ΠΎΠ±Π»Π΅ΠΏΠΈΡ
ΠΈ ΠΊΡΡΡΠΈΠ½ΠΎΠ²ΠΈΠ΄Π½ΠΎΠΉ ΠΈΠ΄Π΅Π½ΡΠΈΡΠΈΡΠΈΡΠΎΠ²Π°Π½ΠΎ 9 ΠΆΠΈΡΠ½ΡΡ
ΠΊΠΈΡΠ»ΠΎΡ. Π Π±ΠΎΠ»ΡΡΠΈΡ
ΠΊΠΎΠ»ΠΈΡΠ΅ΡΡΠ²Π°Ρ
ΡΠΎΠ΄Π΅ΡΠΆΠΈΡΡΡ ΠΏΠ°Π»ΡΠΌΠΈΡΠΈΠ½ΠΎΠ²Π°Ρ (23,55 ΠΌΠ³/Π³), Π² ΠΌΠ΅Π½ΡΡΠΈΡ
β ΡΡΠ΅Π°ΡΠΈΠ½ΠΎΠ²Π°Ρ (2,68 ΠΌΠ³/Π³), ΠΌΠΈΡΠΈΡΡΠΈΠ½ΠΎΠ²Π°Ρ (1,36 ΠΌΠ³/Π³), Π°ΡΠ°Ρ
ΠΈΠ½ΠΎΠ²Π°Ρ (0,87 ΠΌΠ³/Π³) ΠΊΠΈΡΠ»ΠΎΡΡ, ΠΈΠ· Π½Π΅Π½Π°ΡΡΡΠ΅Π½Π½ΡΡ
ΠΊΠΈΡΠ»ΠΎΡ β ΠΎΠ»Π΅ΠΈΠ½ΠΎΠ²Π°Ρ (44,42 ΠΌΠ³/Π³), Π»ΠΈΠ½ΠΎΠ»Π΅Π²Π°Ρ (12,49 ΠΌΠ³/Π³), Π»ΠΈΠ½ΠΎΠ»Π΅Π½ΠΎΠ²Π°Ρ (5,96 ΠΌΠ³/Π³), ΠΏΠ°Π»ΡΠΌΠΈΡΠΎΠ»Π΅ΠΈΠ½ΠΎΠ²Π°Ρ (5,16 ΠΌΠ³/Π³) ΠΈ Π²Π°ΠΊΡΠ΅Π½ΠΎΠ²Π°Ρ (3,79 ΠΌΠ³/Π³). Π ΡΠ΅ΠΌΠ΅Π½Π°Ρ
ΠΎΠ±Π»Π΅ΠΏΠΈΡ
ΠΈ ΠΊΡΡΡΠΈΠ½ΠΎΠ²ΠΈΠ΄Π½ΠΎΠΉ ΡΠΎΠ΄Π΅ΡΠΆΠΈΡΡΡ 8 ΠΆΠΈΡΠ½ΡΡ
ΠΊΠΈΡΠ»ΠΎΡ. Π’ΡΠΈ ΠΈΠ· Π½ΠΈΡ
Π½Π°ΡΡΡΠ΅Π½Π½ΡΠ΅: ΠΏΠ°Π»ΡΠΌΠΈΡΠΈΠ½ΠΎΠ²Π°Ρ (15,89 ΠΌΠ³/Π³), ΡΡΠ΅Π°ΡΠΈΠ½ΠΎΠ²Π°Ρ (2,51 ΠΌΠ³/Π³), ΠΌΠΈΡΠΈΡΡΠΈΠ½ΠΎΠ²Π°Ρ (0,71 ΠΌΠ³/Π³) ΠΈ ΠΏΡΡΡ Π½Π΅Π½Π°ΡΡΡΠ΅Π½Π½ΡΠ΅ β ΠΎΠ»Π΅ΠΈΠ½ΠΎΠ²Π°Ρ (31,41 ΠΌΠ³/Π³), Π»ΠΈΠ½ΠΎΠ»Π΅Π²Π°Ρ (27,03 ΠΌΠ³/Π³), Π»ΠΈΠ½ΠΎΠ»Π΅Π½ΠΎΠ²Π°Ρ (17,00 ΠΌΠ³/Π³), Π²Π°ΠΊΡΠ΅Π½ΠΎΠ²Π°Ρ (2,86 ΠΌΠ³/Π³) ΠΈ ΠΏΠ°Π»ΡΠΌΠΈΡΠΎΠ»Π΅ΠΈΠ½ΠΎΠ²Π°Ρ (2,56 ΠΌΠ³/Π³).
ΠΡΠ²ΠΎΠ΄Ρ. Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ Π°Π½Π°Π»ΠΈΠ·Π° ΡΠ²ΠΈΠ΄Π΅ΡΠ΅Π»ΡΡΡΠ²ΡΡΡ ΠΎ Π±ΠΎΠ³Π°ΡΠΎΠΌ ΠΆΠΈΡΠ½ΠΎΠΊΠΈΡΠ»ΠΎΡΠ½ΠΎΠΌ ΡΠΎΡΡΠ°Π²Π΅ Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΠΎΠ³ΠΎ ΡΠ°ΡΡΠΈΡΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ ΡΡΡΡΡ ΠΎΠ±Π»Π΅ΠΏΠΈΡ
ΠΈ ΠΊΡΡΡΠΈΠ½ΠΎΠ²ΠΈΠ΄Π½ΠΎΠΉ. Π£ΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½Π½Π°Ρ ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΡ β Π½Π°Π»ΠΈΡΠΈΠ΅ ΠΈ ΡΠΎΠΎΡΠ½ΠΎΡΠ΅Π½ΠΈΠ΅ Π² ΠΌΡΠΊΠΎΡΠΈ ΠΈ ΡΠ΅ΠΌΠ΅Π½Π°Ρ
ΠΏΠ°Π»ΡΠΌΠΈΡΠΎΠ»ΠΈΠ½ΠΎΠ²ΠΎΠΉ ΠΈ Π²Π°ΠΊΡΠ΅Π½ΠΎΠ²ΠΎΠΉ ΠΆΠΈΡΠ½ΡΡ
ΠΊΠΈΡΠ»ΠΎΡ β ΡΠ²Π»ΡΠ΅ΡΡΡ Ρ
Π°ΡΠ°ΠΊΡΠ΅ΡΠ½ΡΠΌ ΠΏΡΠΈΠ·Π½Π°ΠΊΠΎΠΌ Π΄Π»Ρ ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΡ ΠΈΠ΄Π΅Π½ΡΠΈΡΠ½ΠΎΡΡΠΈ ΠΎΠ±Π»Π΅ΠΏΠΈΡ
ΠΈ ΡΡΡΡΡ. Π’Π°ΠΊΠΈΠΌ ΠΎΠ±ΡΠ°Π·ΠΎΠΌ, ΡΡΠΎ ΡΡΡΡΠ΅ ΠΌΠΎΠΆΠ΅Ρ Π±ΡΡΡ ΠΏΠ΅ΡΡΠΏΠ΅ΠΊΡΠΈΠ²Π½ΡΠΌ Π΄Π»Ρ ΡΠΎΠ·Π΄Π°Π½ΠΈΡ Π½Π° Π΅Π³ΠΎ ΠΎΡΠ½ΠΎΠ²Π΅ Π»Π΅ΠΊΠ°ΡΡΡΠ²Π΅Π½Π½ΡΡ
ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΎΠ² ΠΈ Π΄ΠΈΠ΅ΡΠΈΡΠ΅ΡΠΊΠΈΡ
Π΄ΠΎΠ±Π°Π²ΠΎΠΊ Π΄Π»Ρ Π»Π΅ΡΠ΅Π½ΠΈΡ ΠΈ ΠΏΡΠΎΡΠΈΠ»Π°ΠΊΡΠΈΠΊΠΈ ΡΠ°Π·Π»ΠΈΡΠ½ΡΡ
Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠΉ ΠΎΡΠ³Π°Π½ΠΈΠ·ΠΌΠ°.Π‘ΡΠΎΠ³ΠΎΠ΄Π½Ρ Π°ΠΊΡΡΠ°Π»ΡΠ½ΡΡΡΡ Π²ΠΈΠ²ΡΠ΅Π½Π½Ρ Π»ΡΠΊΠ°ΡΡΡΠΊΠΈΡ
ΡΠΎΡΠ»ΠΈΠ½ Ρ ΡΡΠ²ΠΎΡΠ΅Π½Π½Π½Ρ Π½Π° ΡΡ
ΠΎΡΠ½ΠΎΠ²Ρ Π»ΡΠΊΠ°ΡΡΡΠΊΠΈΡ
ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΡΠ² Π·Π°ΠΉΠΌΠ°Ρ ΠΎΡΠΎΠ±Π»ΠΈΠ²Π΅ ΠΌΡΡΡΠ΅ Π² Π³Π°Π»ΡΠ·Ρ ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΠΈ ΡΠ° ΡΠ°ΡΠΌΠ°ΡΡΡΡ. ΠΠ½ΡΠ΅ΡΠ΅Ρ Π΄ΠΎ Π²ΠΈΠ²ΡΠ΅Π½Π½Ρ Π²ΠΆΠ΅ Π²ΡΠ΄ΠΎΠΌΠΈΡ
Ρ Π½ΠΎΠ²ΠΈΡ
Π»ΡΠΊΠ°ΡΡΡΠΊΠΈΡ
ΡΠΎΡΠ»ΠΈΠ½ Π²ΡΡΡΠΈΠ·Π½ΡΠ½ΠΎΡ ΡΠ»ΠΎΡΠΈ Π΄Π΅Π΄Π°Π»Ρ Π·ΡΠΎΡΡΠ°Ρ. ΠΠ° ΡΡ
ΠΎΡΠ½ΠΎΠ²Ρ ΡΡΠ²ΠΎΡΡΡΡΡ Π½ΠΎΠ²Ρ Π»ΡΠΊΠ°ΡΡΡΠΊΡ Π·Π°ΡΠΎΠ±ΠΈ ΡΠΎΡΠ»ΠΈΠ½Π½ΠΎΠ³ΠΎ ΠΏΠΎΡ
ΠΎΠ΄ΠΆΠ΅Π½Π½Ρ ΡΠ° Π΄ΡΡΡΠΈΡΠ½Ρ Π΄ΠΎΠ±Π°Π²ΠΊΠΈ, ΡΠΊΡ Π·Π°Π²Π΄ΡΠΊΠΈ ΡΠ²ΠΎΡΠΌΡ ΡΠ½ΡΠΊΠ°Π»ΡΠ½ΠΎΠΌΡ ΡΠΊΠ»Π°Π΄Ρ ΡΠΈΠ½ΡΡΡ ΠΌβΡΠΊΡ Π»ΡΠΊΡΠ²Π°Π»ΡΠ½Ρ ΠΉ ΠΊΠΎΠΌΠΏΠ»Π΅ΠΊΡΠ½Ρ Π΄ΡΡ Π½Π° ΠΎΡΠ³Π°Π½ΠΈ ΠΉ ΡΠΈΡΡΠ΅ΠΌΠΈ Π»ΡΠ΄ΡΡΠΊΠΎΠ³ΠΎ ΠΎΡΠ³Π°Π½ΡΠ·ΠΌΡ. ΠΠΎΠ½ΠΈ ΠΏΡΠ°ΠΊΡΠΈΡΠ½ΠΎ ΠΏΠΎΠ·Π±Π°Π²Π»Π΅Π½Ρ ΠΏΠΎΠ±ΡΡΠ½ΠΈΡ
Π΅ΡΠ΅ΠΊΡΡΠ², Π΄ΠΎ Π½ΠΈΡ
Π½Π΅ ΡΠΎΠ·Π²ΠΈΠ²Π°ΡΡΡΡΡ Π·Π²ΠΈΠΊΠ°Π½Π½Ρ.
ΠΠ΅ΡΠ°. ΠΠΈΠ²ΡΠΈΡΠΈ ΡΠΊΡΡΠ½ΠΈΠΉ ΡΠΊΠ»Π°Π΄ Ρ Π²ΠΌΡΡΡ ΠΆΠΈΡΠ½ΠΈΡ
ΠΊΠΈΡΠ»ΠΎΡ Ρ Π»ΡΠΊΠ°ΡΡΡΠΊΡΠΉ ΡΠΎΡΠ»ΠΈΠ½Π½ΡΠΉ ΡΠΈΡΠΎΠ²ΠΈΠ½Ρ ΠΎΠ±Π»ΡΠΏΠΈΡ
ΠΈ ΠΊΡΡΡΠΈΠ½ΠΎΠ²ΠΈΠ΄Π½ΠΎΡ Π·Π° Π΄ΠΎΠΏΠΎΠΌΠΎΠ³ΠΎΡ Ρ
ΡΠΎΠΌΠ°ΡΠΎΠ³ΡΠ°ΡΡΡΠ½ΠΎΠ³ΠΎ ΠΌΠ΅ΡΠΎΠ΄Ρ. ΠΠΈΡΠ²ΠΈΡΠΈ Ρ
Π°ΡΠ°ΠΊΡΠ΅ΡΠ½Ρ ΠΎΡΠΎΠ±Π»ΠΈΠ²ΡΡΡΡ ΠΆΠΈΡΠ½ΠΎΠΊΠΈΡΠ»ΠΎΡΠ½ΠΎΠ³ΠΎ ΡΠΊΠ»Π°Π΄Ρ Π΄Π»Ρ ΠΌΠΎΠΆΠ»ΠΈΠ²ΠΎΠ³ΠΎ Π²ΠΈΠ·Π½Π°ΡΠ΅Π½Π½Ρ ΡΠ΄Π΅Π½ΡΠΈΡΠ½ΠΎΡΡΡ ΡΠΈΡΠΎΠ²ΠΈΠ½ΠΈ ΠΎΠ±Π»ΡΠΏΠΈΡ
ΠΈ.
ΠΠ°ΡΠ΅ΡΡΠ°Π»ΠΈ ΡΠ° ΠΌΠ΅ΡΠΎΠ΄ΠΈ. ΠΠ±βΡΠΊΡΠ°ΠΌΠΈ Π΄ΠΎΡΠ»ΡΠ΄ΠΆΠ΅Π½Π½Ρ Π±ΡΠ»ΠΈ Π»ΠΈΡΡΡ, ΠΌβΡΠΊΠΎΡΡ ΠΏΠ»ΠΎΠ΄ΡΠ², Π½Π°ΡΡΠ½Π½Ρ ΡΠ° ΠΊΠΎΡΠ° ΠΎΠ±Π»ΡΠΏΠΈΡ
ΠΈ ΠΊΡΡΡΠΈΠ½ΠΎΠ²ΠΈΠ΄Π½ΠΎΡ, Π·Π°Π³ΠΎΡΠΎΠ²Π»Π΅Π½Ρ Π½Π° ΡΠ°ΡΠΌΠ°ΠΊΠΎΠΏΠ΅ΠΉΠ½ΡΠΉ Π΄ΡΠ»ΡΠ½ΡΡ ΠΠ€Π°Π£ (2018 Ρ). ΠΠ½Π°Π»ΡΠ· ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΠ»ΠΈ Π·Π° Π΄ΠΎΠΏΠΎΠΌΠΎΠ³ΠΎΡ Π³Π°Π·ΠΎ-Ρ
ΡΠΎΠΌΠ°ΡΠΎ-ΠΌΠ°Ρ-ΡΠΏΠ΅ΠΊΡΡΠΎΠΌΠ΅ΡΡΠΈΡΠ½ΠΎΠ³ΠΎ ΠΌΠ΅ΡΠΎΠ΄Ρ (ΠΠ₯/ΠΠ‘).
Π Π΅Π·ΡΠ»ΡΡΠ°ΡΠΈ ΡΠ° ΡΡ
ΠΎΠ±Π³ΠΎΠ²ΠΎΡΠ΅Π½Π½Ρ. Π Π΅Π·ΡΠ»ΡΡΠ°ΡΠΈ Π°Π½Π°Π»ΡΠ·Ρ ΡΠ²ΡΠ΄ΡΠ°ΡΡ ΠΏΡΠΎ ΡΠ΅, ΡΠΎ ΠΠ Π‘ ΠΎΠ±Π»ΡΠΏΠΈΡ
ΠΈ ΠΊΡΡΡΠΈΠ½ΠΎΠ²ΠΈΠ΄Π½ΠΎΡ ΠΌΠ°Ρ Π±Π°Π³Π°ΡΠΈΠΉ Ρ ΡΡΠ·Π½ΠΎΠΌΠ°Π½ΡΡΠ½ΠΈΠΉ ΡΠΊΠ»Π°Π΄ Π½Π°ΡΠΈΡΠ΅Π½ΠΈΡ
Ρ Π½Π΅Π½Π°ΡΠΈΡΠ΅Π½ΠΈΡ
ΠΆΠΈΡΠ½ΠΈΡ
ΠΊΠΈΡΠ»ΠΎΡ. Π£ Π»ΠΈΡΡΡ ΠΎΠ±Π»ΡΠΏΠΈΡ
ΠΈ ΠΊΡΡΡΠΈΠ½ΠΎΠ²ΠΈΠ΄Π½ΠΎΡ Π²ΠΈΡΠ²Π»Π΅Π½ΠΎ Π² Π·Π½Π°ΡΠ½ΠΈΡ
ΠΊΡΠ»ΡΠΊΠΎΡΡΡΡ
ΡΠ°ΠΊΡ Π½Π°ΡΠΈΡΠ΅Π½Ρ ΠΆΠΈΡΠ½Ρ ΠΊΠΈΡΠ»ΠΎΡΠΈ: ΠΏΠ°Π»ΡΠΌΡΡΠΈΠ½ΠΎΠ²Ρ (5,33 ΠΌΠ³/Π³), Π±Π΅Π³Π΅Π½ΠΎΠ²Ρ (1,07 ΠΌΠ³/Π³), ΡΡΠ΅Π°ΡΠΈΠ½ΠΎΠ²Ρ (1,03 ΠΌΠ³/Π³), Π°ΡΠ°Ρ
ΡΠ½ΠΎΠ²Ρ (0,91 ΠΌΠ³/Π³), Π»ΡΠ³Π½ΠΎΡΠ΅ΡΠΈΠ½ΠΎΠ²Ρ (0,78 ΠΌΠ³/Π³), ΠΌΠ°ΡΠ³Π°ΡΠΈΠ½ΠΎΠ²Ρ (0,32 ΠΌΠ³/Π³), ΠΌΡΡΠΈΡΡΠΈΠ½ΠΎΠ²Ρ (0,28 ΠΌΠ³/Π³) β Ρ Π½Π΅Π½Π°ΡΠΈΡΠ΅Π½Ρ ΠΆΠΈΡΠ½Ρ ΠΊΠΈΡΠ»ΠΎΡΠΈ β ΠΎΠ»Π΅ΡΠ½ΠΎΠ²Ρ (7,79 ΠΌΠ³/Π³), Π»ΡΠ½ΠΎΠ»Π΅Π²Ρ (2,42 ΠΌΠ³/Π³). ΠΠΈΡΠ½Ρ ΠΊΠΈΡΠ»ΠΎΡΠΈ ΠΊΠΎΡΠΈ ΠΎΠ±Π»ΡΠΏΠΈΡ
ΠΈ ΠΊΡΡΡΠΈΠ½ΠΎΠ²ΠΈΠ΄Π½ΠΎΡΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½Ρ Π½Π°ΡΠΈΡΠ΅Π½ΠΈΠΌΠΈ Π°ΡΠ°Ρ
ΡΠ½ΠΎΠ²ΠΎΡ (20,85 ΠΌΠ³/Π³), ΠΏΠ°Π»ΡΠΌΡΡΠΈΠ½ΠΎΠ²ΠΎΡ (2,14 ΠΌΠ³/Π³), Π΅ΡΡΠΊΠΎΠ²ΠΎΡ (2,09 ΠΌΠ³/Π³), Π³Π΅Π½Π΅ΠΉΠΊΠΎΡΠΈΠ»ΠΎΠ²ΠΎΡ (1,87 ΠΌΠ³/Π³), Π±Π΅Π³Π΅Π½ΠΎΠ²ΠΎΡ (1,38 ΠΌΠ³/Π³) ΠΊΠΈΡΠ»ΠΎΡΠ°ΠΌΠΈ ΡΠ° Π½Π΅Π½Π°ΡΠΈΡΠ΅Π½ΠΈΠΌΠΈ ΠΎΠ»Π΅ΡΠ½ΠΎΠ²ΠΎΡ (5,75 ΠΌΠ³/Π³) Ρ Π»ΡΠ½ΠΎΠ»Π΅Π²ΠΎΡ (4,86 ΠΌΠ³/Π³) ΠΆΠΈΡΠ½ΠΈΠΌΠΈ ΠΊΠΈΡΠ»ΠΎΡΠ°ΠΌΠΈ. Π£ ΠΌβΡΠΊΠΎΡΡ ΠΏΠ»ΠΎΠ΄ΡΠ² ΠΎΠ±Π»ΡΠΏΠΈΡ
ΠΈ ΠΊΡΡΡΠΈΠ½ΠΎΠ²ΠΈΠ΄Π½ΠΎΡ ΡΠ΄Π΅Π½ΡΠΈΡΡΠΊΠΎΠ²Π°Π½ΠΎ 9 ΠΆΠΈΡΠ½ΠΈΡ
ΠΊΠΈΡΠ»ΠΎΡ: Ρ Π²Π΅Π»ΠΈΠΊΠΈΡ
ΠΊΡΠ»ΡΠΊΠΎΡΡΡΡ
ΠΌΡΡΡΠΈΡΡΡΡ ΠΏΠ°Π»ΡΠΌΡΡΠΈΠ½ΠΎΠ²Π° (23,55 ΠΌΠ³/Π³), Ρ ΠΌΠ΅Π½ΡΠΈΡ
β ΡΡΠ΅Π°ΡΠΈΠ½ΠΎΠ²Π° (2,68 ΠΌΠ³/Π³), ΠΌΡΡΠΈΡΡΠΈΠ½ΠΎΠ²Π° (1,36 ΠΌΠ³/Π³), Π°ΡΠ°Ρ
ΡΠ½ΠΎΠ²Π° (0,87 ΠΌΠ³/Π³) ΠΊΠΈΡΠ»ΠΎΡΠΈ; Π·-ΠΏΠΎΠΌΡΠΆ Π½Π΅Π½Π°ΡΠΈΡΠ΅Π½ΠΈΡ
ΠΊΠΈΡΠ»ΠΎΡ β ΠΎΠ»Π΅ΡΠ½ΠΎΠ²Π° (44,42 ΠΌΠ³/Π³), Π»ΡΠ½ΠΎΠ»Π΅Π²Π° (12,49 ΠΌΠ³/Π³), Π»ΡΠ½ΠΎΠ»Π΅Π½ΠΎΠ²Π° (5,96 ΠΌΠ³/Π³), ΠΏΠ°Π»ΡΠΌΡΡΠΎΠ»Π΅ΡΠ½ΠΎΠ²Π° (5,16 ΠΌΠ³/Π³) Ρ Π²Π°ΠΊΡΠ΅Π½ΠΎΠ²Π° (3,79 ΠΌΠ³/Π³) ΠΊΠΈΡΠ»ΠΎΡΠΈ. Π£ Π½Π°ΡΡΠ½Π½Ρ ΠΎΠ±Π»ΡΠΏΠΈΡ
ΠΈ ΠΊΡΡΡΠΈΠ½ΠΎΠ²ΠΈΠ΄Π½ΠΎΡ Π²ΠΈΡΠ²Π»Π΅Π½ΠΎ 8 ΠΆΠΈΡΠ½ΠΈΡ
ΠΊΠΈΡΠ»ΠΎΡ. Π’ΡΠΈ Π· Π½ΠΈΡ
Π½Π°ΡΠΈΡΠ΅Π½Ρ β ΠΏΠ°Π»ΡΠΌΡΡΠΈΠ½ΠΎΠ²Π° (15,89 ΠΌΠ³/Π³), ΡΡΠ΅Π°ΡΠΈΠ½ΠΎΠ²Π° (2,51 ΠΌΠ³/Π³), ΠΌΡΡΠΈΡΡΠΈΠ½ΠΎΠ²Π° (0,71 ΠΌΠ³/Π³) β ΡΠ° ΠΏβΡΡΡ Π½Π΅Π½Π°ΡΠΈΡΠ΅Π½Ρ, Π° ΡΠ°ΠΌΠ΅: ΠΎΠ»Π΅ΡΠ½ΠΎΠ²Π° (31,41 ΠΌΠ³/Π³), Π»ΡΠ½ΠΎΠ»Π΅Π²Π° (27,03 ΠΌΠ³/Π³), Π»ΡΠ½ΠΎΠ»Π΅Π½ΠΎΠ²Π° (17,00 ΠΌΠ³/Π³), Π²Π°ΠΊΡΠ΅Π½ΠΎΠ²Π° (2,86 ΠΌΠ³/Π³) ΡΠ°ΠΏΠ°Π»ΡΠΌΡΡΠΎΠ»Π΅ΡΠ½ΠΎΠ²Π° (2,56 ΠΌΠ³/Π³).
ΠΠΈΡΠ½ΠΎΠ²ΠΊΠΈ. Π Π΅Π·ΡΠ»ΡΡΠ°ΡΠΈ Π°Π½Π°Π»ΡΠ·Ρ ΡΠ²ΡΠ΄ΡΠ°ΡΡ ΠΏΡΠΎ Π±Π°Π³Π°ΡΠΈΠΉ ΠΆΠΈΡΠ½ΠΎΠΊΠΈΡΠ»ΠΎΡΠ½ΠΈΠΉ ΡΠΊΠ»Π°Π΄ Π»ΡΠΊΠ°ΡΡΡΠΊΠΎΡ ΡΠΎΡΠ»ΠΈΠ½Π½ΠΎΡ ΡΠΈΡΠΎΠ²ΠΈΠ½ΠΈ ΠΎΠ±Π»ΡΠΏΠΈΡ
ΠΈ ΠΊΡΡΡΠΈΠ½ΠΎΠ²ΠΈΠ΄Π½ΠΎΡ. ΠΠΈΡΠ²Π»Π΅Π½ΠΎ Ρ
Π°ΡΠ°ΠΊΡΠ΅ΡΠ½Ρ ΠΎΡΠΎΠ±Π»ΠΈΠ²ΡΡΡΡ β Π½Π°ΡΠ²Π½ΡΡΡΡ Ρ ΡΠΏΡΠ²Π²ΡΠ΄Π½ΠΎΡΠ΅Π½Π½Ρ Π² ΠΌβΡΠΊΠΎΡΡ ΠΉ Π½Π°ΡΡΠ½Π½Ρ ΠΏΠ°Π»ΡΠΌΡΡΠΎΠ»Π΅ΡΠ½ΠΎΠ²ΠΎΡ ΡΠ° Π²Π°ΠΊΡΠ΅Π½ΠΎΠ²ΠΎΡ ΠΆΠΈΡΠ½ΠΈΡ
ΠΊΠΈΡΠ»ΠΎΡ, ΡΠΎ Ρ ΡΡΡΡΡΠ²ΠΈΠΌ Π΄Π»Ρ Π²ΠΈΠ·Π½Π°ΡΠ΅Π½Π½Ρ ΡΠ΄Π΅Π½ΡΠΈΡΠ½ΠΎΡΡΡ ΡΠΈΡΠΎΠ²ΠΈΠ½ΠΈ ΠΎΠ±Π»ΡΠΏΠΈΡ
ΠΈ. ΠΡΠΆΠ΅, Π΄ΠΎΡΠ»ΡΠ΄ΠΆΡΠ²Π°Π½Π° ΡΠΎΡΠ»ΠΈΠ½Π½Π° ΡΠΈΡΠΎΠ²ΠΈΠ½Π° ΠΌΠΎΠΆΠ΅ Π±ΡΡΠΈ ΠΏΠ΅ΡΡΠΏΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡ Π΄Π»Ρ ΡΡΠ²ΠΎΡΠ΅Π½Π½Ρ Π½Π° ΡΡ ΠΎΡΠ½ΠΎΠ²Ρ Π»ΡΠΊΠ°ΡΡΡΠΊΠΈΡ
ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΡΠ² Ρ Π΄ΡΡΡΠΈΡΠ½ΠΈΡ
Π΄ΠΎΠ±Π°Π²ΠΎΠΊ Π΄Π»Ρ Π»ΡΠΊΡΠ²Π°Π½Π½Ρ ΡΠ° ΠΏΡΠΎΡΡΠ»Π°ΠΊΡΠΈΠΊΠΈ ΡΡΠ·Π½ΠΈΡ
Π·Π°Ρ
Π²ΠΎΡΡΠ²Π°Π½Ρ ΠΎΡΠ³Π°Π½ΡΠ·ΠΌΡ
Alzheimer's disease under the mask of stroke
Cognitive impairments (CIs) are common in poststroke patients. The basis for this condition is frequently a neurodegenerative process and most often Alzheimer's disease (AD). Stroke may promote the manifestation of clinically asymptomatic AD, worsen prestroke cognitive deficit or merely manifest prestroke CIs.The paper discusses the epidemiology, risk factors, and pathogenesis of poststroke CIs, current methods for its diagnosis, as well as symptomatic and pathogenetic treatment. The most informative method for the diagnosis of poststroke CIs is neuropsychological examination that should be made in the early poststroke period (if the patient's consciousness is clear). The most common screening tests include mini-mental state examination (the most sensitive to evaluate cognitive dysfunction in Alzheimer type dementias) and the Montreal cognitive assessment. Magnetic resonance imaging of the brain, positron emission tomography, cerebrospinal fluid examination, and genetic testing are used to reveal AD at its preclinical stages. Preventive measures include regular physical activity, a balanced diet, and sufficient mental workload. The prevention of stroke and other cardiovascular diseases are also important.The major groups of drugs used to treat AD and vascular CIs are acetylcholinesterase inhibitors and N-methyl-D-aspartate receptor antagonists. It is expedient to use glutamatergic and acetylcholinergic therapy earlier in patients with obvious CIs that are unassociated with emotional problems and disturbance of consciousness. Akatinol memantine is a drug that can be regarded not only as a symptomatic but also pathogenetic agent
ΠΠ΅ΡΠΎΠ΄ Π³Π΅Π½Π΅ΡΡΠ²Π°Π½Π½Ρ ΡΠ°ΡΡΠΎΠ½Π°Π»ΡΠ½ΠΈΡ ΡΡ Π΅ΠΌ ΡΠΎΠ·ΠΊΡΠΎΡ ΡΡΠ»ΠΎΠ½Π½ΠΈΡ ΠΌΠ°ΡΠ΅ΡΡΠ°Π»ΡΠ² Π½Π° Π΄Π΅ΡΠ°Π»Ρ Π³Π°Π»Π°Π½ΡΠ΅ΡΠ΅ΠΉΠ½ΠΈΡ Π²ΠΈΡΠΎΠ±ΡΠ²
Π‘ΡΠ°ΡΡΡ ΠΏΡΠΈΡΠ²ΡΡΠ΅Π½Π° ΡΠΎΠ·ΡΠΎΠ±ΡΡ ΠΌΠ΅ΡΠΎΠ΄Ρ Π°Π²ΡΠΎΠΌΠ°ΡΠΈΠ·ΠΎΠ²Π°Π½ΠΎΠ³ΠΎ Π³Π΅Π½Π΅ΡΡΠ²Π°Π½Π½Ρ ΡΠ°ΡΡΠΎΠ½Π°Π»ΡΠ½ΠΈΡ
ΡΡ
Π΅ΠΌ ΡΠΎΠ·ΠΊΡΠΎΡ ΡΡΠ»ΠΎΠ½Π½ΠΈΡ
ΠΌΠ°ΡΠ΅ΡΡΠ°Π»ΡΠ² Π½Π° Π΄Π΅ΡΠ°Π»Ρ ΡΠΊΡΡΠ³Π°Π»Π°Π½ΡΠ΅ΡΠ΅Ρ. ΠΠ°ΠΏΡΠΎΠΏΠΎΠ½ΠΎΠ²Π°Π½ΠΈΠΉ ΠΌΠ΅ΡΠΎΠ΄ ΡΠ΅Π°Π»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠΉ Π² ΠΏΡΠΎΠ³ΡΠ°ΠΌΠ½ΠΈΠΉ ΠΏΡΠΎΠ΄ΡΠΊΡ. ΠΡΠΎΠ³ΡΠ°ΠΌΠ½ΠΈΠΉ ΠΏΡΠΎΠ΄ΡΠΊΡ ΠΌΠ°Ρ Π΄ΡΡΠΆΠ½ΡΠΉ ΡΠ½ΡΠ΅ΡΡΠ΅ΠΉΡ ΡΠ° Π½Π΅ ΠΏΠΎΡΡΠ΅Π±ΡΡ Π΄ΠΎΠ΄Π°ΡΠΊΠΎΠ²ΠΈΡ
Π·Π½Π°Π½Ρ Π· ΠΊΠΎΠΌΠΏβΡΡΠ΅ΡΠ½ΠΈΡ
Π½Π°ΡΠΊ ΠΏΡΠΈ ΡΠΎΠ±ΠΎΡΡ Π· Π½ΠΈΠΌ.Develop an algorithm for generating rational schemes for cutting rolled materials into haberdashery details
Algorithm for generation of rational schemes for cutting roll materials on details of hardware products
Develop an algorithm for generating rational schemes for cutting rolled materials into haberdashery details
Association between atopic and non-atopic diseases at children.
The paper presents the data of the association analysis betΒween the diseases composig the atopic march (AM) in children β atopic dermatitis (AD), seasonal rhinoconjunctivitis (SARC) and perennial allergic rhinitis (PAR), bronchial asthma (BA), with non-atopic allergic diseases β acute and recurrent urticaria (AcU/RecU), Quincke edema (QE), and also with diseases of the digestive system (DS) β functional disorders of the biliary system (FDBS) and reactive pancreatitis (RP). The association between AD and food allergy (FA) in children has been determined, which is recorded as a direct association. A direct association was established between chronic infectious diseases of the upper respiratory tract and the PAR as well as BA. The lack of association between atopic and non-atopic allergic diseases had been confirmed. The association between FDBS and RP and non-atopic allergic diseases in children had been determined β AcU/RecU, QE
Synthesis, Morphology, and Optical Properties of Au/CdS Hybrid Nanocomposites Stabilized by Branched Polymer Matrices
Metal/semiconductor (Au/CdS) nanocomposites were synthesized in the solution of branched D-g-PAA polymer. TEM and DLS of Au/CdS/D-g-PAA nanocomposites revealed complicated nanocomposite structure consisting of the Au nanoparticles (NPs) of 6βnm in size surrounded by small CdS NPs with size of 3βnm. These nanocomposites formed the aggregates-clusters with average size of 50β800βnm. Absorption spectra of Au/CdS nanocomposites consist of the bands of excitons in CdS NPs and surface plasmons in Au ones. The surface plasmon band of gold NPs is red shifted and broadened in Au/CdS/D-g-PAA nanocomposites comparing to the one of Au NPs in Au/D-g-PAA proving the fact of close location of CdS and Au NPs in the synthesized Au/CdS/D-g-PAA nanocomposites. The PL spectra of Au/CdS nanocomposites originate from the radiative transitions in excitons in CdS NPs. The 4-fold increase of intensity of free exciton PL is observed for CdS NPs in Au/CdS/D-g-PAA comparing to CdS ones in CdS/D-g-PAA that is due to PL enhancement by local field of surface plasmons of Au NPs. Also, the 12-fold decrease of intensity of localized exciton PL is observed for CdS NPs in Au/CdS/D-g-PAA comparing to CdS ones in CdS/D-g-PAA. Most probably, it is due to passivation of the surface of CdS NPs carried out by the Au ones
Association between atopic and non-atopic diseases at children.
ΠΡΡΠΎΡΠΈΠ°ΡΠΈΡ ΠΌΠ΅ΠΆΠ΄Ρ Π°ΡΠΎΠΏΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ ΠΈ Π½Π΅Π°ΡΠΎΠΏΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ Π°Π»Π»Π΅ΡΠ³ΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ Π±ΠΎΠ»Π΅Π·Π½ΡΠΌΠΈ Ρ Π΄Π΅ΡΠ΅ΠΉ.
ΠΠ±Π°ΡΡΡΠΎΠ² Π.Π., ΠΠΈΡΡΡΠΊΠΎΠ²ΡΠΊΠΈΠΉ Π.Π., ΠΠ°ΡΠΌΠ΅Π½ΠΊΠΎ Π.Π., ΠΡΠ»ΠΈΠ΅Π²Π° Π., ΠΠΎΠ²ΡΡΠ½ΠΎΠ²ΡΠΊΠ°Ρ Π., Π€ΠΈΠ»Π°ΡΠΎΠ²Π° Π.Π. Π ΡΡΠ°ΡΡΠ΅
ΠΏΡΠΈΠ²Π΅Π΄Π΅Π½Ρ Π΄Π°Π½Π½ΡΠ΅ Π°Π½Π°Π»ΠΈΠ·Π° Π°ΡΡΠΎΡΠΈΠ°ΡΠΈΠΈ ΠΌΠ΅ΠΆΠ΄Ρ Π±ΠΎΠ»Π΅Π·Π½ΡΠΌΠΈ, ΡΠΎΡΡΠ°Π²Π»ΡΡΡΠΈΠΌΠΈ Π°ΡΠΎΠΏΠΈΡΠ΅ΡΠΊΠΈΠΉ ΠΌΠ°ΡΡ (ΠΠ) Ρ Π΄Π΅ΡΠ΅ΠΉ β
Π°ΡΠΎΠΏΠΈΡΠ΅ΡΠΊΠΈΠΌ Π΄Π΅ΡΠΌΠ°ΡΠΈΡΠΎΠΌ (ΠΠ), ΡΠ΅Π·ΠΎΠ½Π½ΡΠΌ Π°Π»Π»Π΅ΡΠ³ΠΈΡΠ΅ΡΠΊΠΈΠΌ ΡΠΈΠ½ΠΎΠΊΠΎΠ½ΡΡΠ½ΠΊΡΠΈΠ²ΠΈΡΠΎΠΌ (Π‘ΠΠ Π) ΠΈ ΠΊΡΡΠ³Π»ΠΎΠ³ΠΎΠ΄ΠΈΡΠ½ΡΠΌ
Π°Π»Π»Π΅ΡΠ³ΠΈΡΠ΅ΡΠΊΠΈΠΌ ΡΠΈΠ½ΠΈΡΠΎΠΌ (ΠΠΠ ), Π±ΡΠΎΠ½Ρ
ΠΈΠ°Π»ΡΠ½ΠΎΠΉ Π°ΡΡΠΌΠΎΠΉ (ΠΠ) β Ρ Π½Π΅Π°ΡΠΎΠΏΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ Π°Π»Π»Π΅ΡΠ³ΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ Π±ΠΎΠ»Π΅Π·Π½ΡΠΌΠΈ β
ΠΎΡΡΡΠΎΠΉ ΠΈ ΡΠ΅ΡΠΈΠ΄ΠΈΠ²ΠΈΡΡΡΡΠ΅ΠΉ ΠΊΡΠ°ΠΏΠΈΠ²Π½ΠΈΡΠ΅ΠΉ (ΠΠ/Π Π), ΠΎΡΡΠΊΠΎΠΌ ΠΠ²ΠΈΠ½ΠΊΠ΅ (ΠΠΠ²), Π° ΡΠ°ΠΊΠΆΠ΅ Π±ΠΎΠ»Π΅Π·Π½ΡΠΌΠΈ ΠΏΠΈΡΠ΅Π²Π°ΡΠΈΡΠ΅Π»ΡΠ½ΠΎΠΉ
ΡΠΈΡΡΠ΅ΠΌΡ (ΠΠ‘) β ΡΡΠ½ΠΊΡΠΈΠΎΠ½Π°Π»ΡΠ½ΡΠΌΠΈ ΡΠ°ΡΡΡΡΠΎΠΉΡΡΠ²Π°ΠΌΠΈ Π±ΠΈΠ»ΠΈΠ°ΡΠ½ΠΎΠΉ ΡΠΈΡΡΠ΅ΠΌΡ (Π€Π ΠΠ‘) ΠΈ ΡΠ΅Π°ΠΊΡΠΈΠ²Π½ΡΠΌ ΠΏΠ°Π½ΠΊΡΠ΅Π°ΡΠΈΡΠΎΠΌ
(Π Π). ΠΠΏΡΠ΅Π΄Π΅Π»Π΅Π½Ρ Π°ΡΡΠΎΡΠΈΠ°ΡΠΈΠΈ ΠΌΠ΅ΠΆΠ΄Ρ ΠΠ, ΠΠ ΠΈ ΠΏΠΈΡΠ΅Π²ΠΎΠΉ Π°Π»Π»Π΅ΡΠ³ΠΈΠ΅ΠΉ (ΠΠ) Ρ Π΄Π΅ΡΠ΅ΠΉ, ΡΡΠΎ Π·Π°ΡΠΈΠΊΡΠΈΡΠΎΠ²Π°Π½ΠΎ Π² Π²ΠΈΠ΄Π΅
ΠΏΡΡΠΌΠΎΠΉ ΠΊΠΎΡΡΠ΅Π»ΡΡΠΈΠΎΠ½Π½ΠΎΠΉ ΡΠ²ΡΠ·ΠΈ. ΠΠΏΡΠ΅Π΄Π΅Π»Π΅Π½Π° ΠΏΡΡΠΌΠ°Ρ Π°ΡΡΠΎΡΠΈΠ°ΡΠΈΡ ΠΌΠ΅ΠΆΠ΄Ρ Ρ
ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΎΠ½Π½ΡΠΌΠΈ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡΠΌΠΈ
Π²Π΅ΡΡ
Π½ΠΈΡ
Π΄ΡΡ
Π°ΡΠ΅Π»ΡΠ½ΡΡ
ΠΏΡΡΠ΅ΠΉ ΠΈ Π‘ΠΠ Π, ΠΠΠ ΠΈ ΠΠ. ΠΠΎΠ΄ΡΠ²Π΅ΡΠΆΠ΄Π΅Π½ΠΎ ΠΎΡΡΡΡΡΡΠ²ΠΈΠ΅ ΡΠ²ΡΠ·ΠΈ ΠΌΠ΅ΠΆΠ΄Ρ Π°ΡΠΎΠΏΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ
ΠΈ Π½Π΅Π°ΡΠΎΠΏΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ Π°Π»Π»Π΅ΡΠ³ΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ Π±ΠΎΠ»Π΅Π·Π½ΡΠΌΠΈ. ΠΡΡΠ²Π»Π΅Π½Ρ Π°ΡΡΠΎΡΠΈΠ°ΡΠΈΠΈ ΠΌΠ΅ΠΆΠ΄Ρ Π€Π ΠΠ‘, Π Π ΠΈ Π½Π΅Π°ΡΠΎΠΏΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ
Π°Π»Π»Π΅ΡΠ³ΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ Π±ΠΎΠ»Π΅Π·Π½ΡΠΌΠΈ Ρ Π΄Π΅ΡΠ΅ΠΉ β ΠΠ/Π Π, ΠΠΠ²
- β¦